Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. ,(1996) , 10.1016/S0140-6736(96)03409-5

H Bartelink, F Roelofsen, F Eschwege, P Rougier, J F Bosset, D G Gonzalez, D Peiffert, M van Glabbeke, M Pierart, Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. Journal of Clinical Oncology. ,vol. 15, pp. 2040- 2049 ,(1997) , 10.1200/JCO.1997.15.5.2040

Christine B Ambrosone, Chunqiao Tian, Jiyoung Ahn, Silke Kropp, Irmgard Helmbold, Dietrich von Fournier, Wulf Haase, Marie Luise Sautter-Bihl, Frederik Wenz, Jenny Chang-Claude, Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study Breast Cancer Research. ,vol. 8, pp. 1- 7 ,(2006) , 10.1186/BCR1526

Ralf-Dieter Hofheinz, Frederik Wenz, Stefan Post, Axel Matzdorff, Stephan Laechelt, Jörg T Hartmann, Lothar Müller, Hartmut Link, Markus Moehler, Erika Kettner, Elisabeth Fritz, Udo Hieber, Hans Walter Lindemann, Martina Grunewald, Stephan Kremers, Christian Constantin, Matthias Hipp, Gernot Hartung, Deniz Gencer, Peter Kienle, Iris Burkholder, Andreas Hochhaus, Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncology. ,vol. 13, pp. 579- 588 ,(2012) , 10.1016/S1470-2045(12)70116-X

Jose G. Bazan, Wendy Hara, Annie Hsu, Pamela A. Kunz, James Ford, George A. Fisher, Mark L. Welton, Andrew Shelton, Daniel S. Kapp, Albert C. Koong, Karyn A. Goodman, Daniel T. Chang, Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. ,vol. 117, pp. 3342- 3351 ,(2011) , 10.1002/CNCR.25901

Damien C Weber, John M Kurtz, Abdelkarim S Allal, The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 50, pp. 675- 680 ,(2001) , 10.1016/S0360-3016(01)01510-3

S T Pullarkat, J Stoehlmacher, V Ghaderi, Y-P Xiong, S A Ingles, A Sherrod, R Warren, D Tsao-Wei, S Groshen, H-J Lenz, Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics Journal. ,vol. 1, pp. 65- 70 ,(2001) , 10.1038/SJ.TPJ.6500012

Gloria M. Petersen, Paolo Boffetta, Carcinogenesis of pancreatic cancer: Challenges, collaborations, progress Molecular Carcinogenesis. ,vol. 51, pp. 1- 2 ,(2012) , 10.1002/MC.20876

Harry H Yoon, Paul J Catalano, Kathleen M Murphy, Todd C Skaar, Santosh Philips, Mark Powell, Elizabeth A Montgomery, Michael J Hafez, Steven M Offer, Geoffrey Liu, Stephen J Meltzer, Xifeng Wu, Arlene A Forastiere, Al B Benson, Lawrence R Kleinberg, Michael K Gibson, Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group BMC Cancer. ,vol. 11, pp. 176- 176 ,(2011) , 10.1186/1471-2407-11-176

Maarten J. Deenen, Luc Dewit, Henk Boot, Jos H. Beijnen, Jan H.M. Schellens, Annemieke Cats, Simultaneous Integrated Boost–Intensity Modulated Radiation Therapy With Concomitant Capecitabine and Mitomycin C for Locally Advanced Anal Carcinoma: A Phase 1 Study International Journal of Radiation Oncology Biology Physics. ,vol. 85, ,(2013) , 10.1016/J.IJROBP.2012.12.008